Bethania Blum

In vitro and in vivo experimental models for drug screening and development for Chagas disease

Álvaro J. Romanha, Solange L. de Castro, Maria de Nazaré Correia Soeiro et al. · Memórias do Instituto Oswaldo Cruz · 2010 · 349 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +17

Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial

Faustino Torrico, Joaquím Gascón, Lourdes Ortiz et al. · The Lancet Infectious Diseases · 2018 · 297 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +6

New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial

Faustino Torrico, Joaquím Gascón, Fabiana Barreira et al. · The Lancet Infectious Diseases · 2021 · 199 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial

María‐Jesús Pinazo, Colin Forsyth, Irene Losada et al. · The Lancet Infectious Diseases · 2024 · 56 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +5

A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease

Faustino Torrico, Joaquím Gascón, Lourdes Ortiz et al. · Clinical Infectious Diseases · 2022 · 52 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +7